Work

Design of a Phase 3, Randomized, Placebo-controlled Trial of Tofersen Initiated in Clinically Pre-symptomatic SOD1 Mutation Carriers with a Longitudinal Natural History Run-in (2285)

Year: 2021

Type: article

Study design: Study Protocol

Source: Neurology

DOI: 10.1212/wnl.96.15_supplement.2285

Authors: Michael Benatar, Joanne Wuu, Peter M. Andersen, Jinsy Andrews, Robert C. Bucelli, Markus Otto, Toby A. Ferguson, Weiping Chen, Laura Fanning, Danielle Graham, Peng Sun, Yingying Liu, Janice Wong, Stephanie Fradette

Institutions: University of Miami, Umeå University, Columbia University, Washington University in St. Louis, Universität Ulm, Biogen (United States)

Language: English

Topic: Amyotrophic Lateral Sclerosis Research

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4389449596

FWCI:

Cites:

Cited by: 1

Related to: 10